Search Page

1

Cite

Share

Statins and cancer risk: a meta-analysis.

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Dale KM, et al. JAMA. 2006 Jan 4;295(1):74-80. doi: 10.1001/jama.295.1.74. JAMA. 2006. PMID: 16391219

Cite

Share

2

Cite

Share

Impact of statin dosing intensity on transaminase and creatine kinase.

Dale KM, White CM, Henyan NN, Kluger J, Coleman CI. Dale KM, et al. Am J Med. 2007 Aug;120(8):706-12. doi: 10.1016/j.amjmed.2006.07.033. Am J Med. 2007. PMID: 17679130

Cite

Share

3

Cite

Share

The relationship between statin use and atrial fibrillation.

Patel AA, White CM, Shah SA, Dale KM, Kluger J, Coleman CI. Patel AA, et al. Among authors: dale km. Curr Med Res Opin. 2007 May;23(5):1177-85. doi: 10.1185/030079907x188026. Curr Med Res Opin. 2007. PMID: 17519085

Cite

Share

4

Cite

Share

Impact of gender on statin efficacy.

Dale KM, Coleman CI, Shah SA, Patel AA, Kluger J, White CM. Dale KM, et al. Curr Med Res Opin. 2007 Mar;23(3):565-74. doi: 10.1185/030079906X167516. Curr Med Res Opin. 2007. PMID: 17355737 Review.

Cite

Share

5

Cite

Share

Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.

Dale KM, White CM. Dale KM, et al. Ann Pharmacother. 2007 Apr;41(4):599-605. doi: 10.1345/aph.1H524. Epub 2007 Mar 27. Ann Pharmacother. 2007. PMID: 17389667 Review.

Cite

Share

6

Cite

Share

Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III).

Coleman CI, Kluger J, Dale K, Sander S, Gallagher R, Reinhart K, Henyan N, White CM. Coleman CI, et al. Expert Opin Pharmacother. 2008 Jan;9(1):7-13. doi: 10.1517/14656566.9.1.7. Expert Opin Pharmacother. 2008. PMID: 18076334 Clinical Trial.

Cite

Share

7

Cite

Share

Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator.

Baker WL, Kluger J, White CM, Dale KM, Silver BB, Coleman CI. Baker WL, et al. Among authors: dale km. Ann Pharmacother. 2009 Apr;43(4):569-76. doi: 10.1345/aph.1L640. Epub 2009 Mar 31. Ann Pharmacother. 2009. PMID: 19336644 Clinical Trial.

Cite

Share

8

Cite

Share

The use of intravenous amiodarone for chemical conversion of atrial fibrillation.

Dale K, White CM. Dale K, et al. Conn Med. 2006 Aug;70(7):433-7. Conn Med. 2006. PMID: 16937720 Review. No abstract available.

Cite

Share

9

Cite

Share

Moxifloxacin and torsade de pointes.

Dale KM, Lertsburapa K, Kluger J, White CM. Dale KM, et al. Ann Pharmacother. 2007 Feb;41(2):336-40. doi: 10.1345/aph.1H474. Epub 2007 Feb 6. Ann Pharmacother. 2007. PMID: 17284508

Cite

Share

10

Cite

Share

Impact of catecholamines on the QTc interval in patients at high risk of sudden death.

Mc Bride BF, Kalus JS, Guertin DC, Dale KM, Kluger J, White CM. Mc Bride BF, et al. Among authors: dale km. Conn Med. 2007 Sep;71(8):465-8. Conn Med. 2007. PMID: 17902384 Clinical Trial. No abstract available.

Cite

Share